Chronic Kidney Disease(CKD)
50
23
28
8
Key Insights
Highlights
Success Rate
89% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
2.0%
1 terminated out of 50 trials
88.9%
+2.3% vs benchmark
10%
5 trials in Phase 3/4
25%
2 of 8 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 8 completed trials
Clinical Trials (50)
Intensification of Blood Pressure Lowering Therapeutics Based on Diuretics Versus Usual Management for Uncontrolled Hypertension IN Patients With Moderate to Severe Chronic Kidney Disease
Monocytes in Subjects With Type 1 Diabetes and Chronic Kidney Disease
Implementation pRogram to Improve Screening and Management for CKD in Diabetes (Program 1) (IRIS-CKD)
Implementation pRogram to Improve Screening and Management for CKD in Diabetes (IRIS-CKD) (Program 2)
Routine Validation and Reproducibility Testing of Laboratory Assays and Research Techniques Used for Endocrine, Cardiometabolic, and Musculoskeletal Disorder Research (VALD)
Kidney Function in People With Cystic Fibrosis in the Era of HEMT
Assessment of Worldwide Acute Kidney Injury Epidemiology in Neonates 2.0
An Intervention to Reduce Sedentary Behavior for Adults With Chronic Kidney Disease
Medication Reconciliation in Hospitalized CKD Patients : A Quasi-Experimental Study
SIRAKI 02 Posthoc Analysis.
Virtual Nephrologist
Efficacy and Safety of Finerenone and Empagliflozin in Delaying Renal Function Progression After Radical Nephrectomy in High-Risk CKD Patients: A Multicenter RCT
MEMRI and Kidney Disease
A Biomarker-targeted Clinical Trial to Optimize Treatment for Patients With Chronic Kidney Disease
AP301 Efficacy and Safety in Chinese Dialysis Patients With Hyperphosphatemia
Algae Effects in Markers of Cardiovascular Risk and Gut Microbiome
Evaluating the Effectiveness of Respiratory Muscle Training in Pediatric Kidney Transplant Patient
Cardiovascular-Kidney-Metabolic Syndrome in Shanghai Zicitizens
Investigation of the Effects of Omega-3 Supplementation in Chronic Kidney Disease Patients Diagnosed With Coronary Artery Disease and Dyslipidemia
Validation of a Proteomic Biomarker to Predict Progression of Chronic Kidney Disease